162 related articles for article (PubMed ID: 21460850)
1. TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1.
Jin HO; Seo SK; Kim YS; Woo SH; Lee KH; Yi JY; Lee SJ; Choe TB; Lee JH; An S; Hong SI; Park IC
Oncogene; 2011 Sep; 30(35):3792-801. PubMed ID: 21460850
[TBL] [Abstract][Full Text] [Related]
2. Activating transcription factor 4 and CCAAT/enhancer-binding protein-beta negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stress.
Jin HO; Seo SK; Woo SH; Kim ES; Lee HC; Yoo DH; An S; Choe TB; Lee SJ; Hong SI; Rhee CH; Kim JI; Park IC
Free Radic Biol Med; 2009 Apr; 46(8):1158-67. PubMed ID: 19439225
[TBL] [Abstract][Full Text] [Related]
3. Redd1 inhibits the invasiveness of non-small cell lung cancer cells.
Jin HO; Seo SK; Woo SH; Kim YS; Hong SE; Yi JY; Noh WC; Kim EK; Lee JK; Hong SI; Choe TB; Park IC
Biochem Biophys Res Commun; 2011 Apr; 407(3):507-11. PubMed ID: 21414293
[TBL] [Abstract][Full Text] [Related]
4. Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.
Ben Sahra I; Regazzetti C; Robert G; Laurent K; Le Marchand-Brustel Y; Auberger P; Tanti JF; Giorgetti-Peraldi S; Bost F
Cancer Res; 2011 Jul; 71(13):4366-72. PubMed ID: 21540236
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression.
Kim YS; Jin HO; Seo SK; Woo SH; Choe TB; An S; Hong SI; Lee SJ; Lee KH; Park IC
Biochem Pharmacol; 2011 Aug; 82(3):216-26. PubMed ID: 21601561
[TBL] [Abstract][Full Text] [Related]
6. SP600125 negatively regulates the mammalian target of rapamycin via ATF4-induced Redd1 expression.
Jin HO; Seo SK; Woo SH; Kim ES; Lee HC; Yoo DH; Choe TB; Hong SI; Kim JI; Park IC
FEBS Lett; 2009 Jan; 583(1):123-7. PubMed ID: 19059405
[TBL] [Abstract][Full Text] [Related]
7. Regulation of mTOR and cell growth in response to energy stress by REDD1.
Sofer A; Lei K; Johannessen CM; Ellisen LW
Mol Cell Biol; 2005 Jul; 25(14):5834-45. PubMed ID: 15988001
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid-induced cytotoxicity through endoplasmic reticulum stress triggered REDD1-mTOR pathway in breast cancer cells.
Lan YC; Chang CL; Sung MT; Yin PH; Hsu CC; Wang KC; Lee HC; Tseng LM; Chi CW
Anticancer Res; 2013 Sep; 33(9):3807-14. PubMed ID: 24023313
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic target of rapamycin (mTOR) dependent regulation of thioredoxin interacting protein (TXNIP) transcription in hypoxia.
Wong RW; Hagen T
Biochem Biophys Res Commun; 2013 Mar; 433(1):40-6. PubMed ID: 23454121
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor of activated T-cell c3 inhibition of mammalian target of rapamycin signaling through induction of regulated in development and DNA damage response 1 in human intestinal cells.
Zhou Y; Wang Q; Guo Z; Weiss HL; Evers BM
Mol Biol Cell; 2012 Aug; 23(15):2963-72. PubMed ID: 22696685
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death.
Yang CS; Matsuura K; Huang NJ; Robeson AC; Huang B; Zhang L; Kornbluth S
Oncogene; 2015 Jun; 34(25):3264-72. PubMed ID: 25151963
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced regulation of mTOR signaling by miR-7 targeting REDD1.
Seong M; Lee J; Kang H
J Cell Biochem; 2019 Mar; 120(3):4523-4532. PubMed ID: 30302791
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 influences stress-signalling by reducing the expression of the mTOR-inhibitor REDD1 in a STAT3-dependent manner.
Pinno J; Bongartz H; Klepsch O; Wundrack N; Poli V; Schaper F; Dittrich A
Cell Signal; 2016 Aug; 28(8):907-16. PubMed ID: 27094713
[TBL] [Abstract][Full Text] [Related]
14. mTOR signaling, function, novel inhibitors, and therapeutic targets.
Watanabe R; Wei L; Huang J
J Nucl Med; 2011 Apr; 52(4):497-500. PubMed ID: 21421716
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
16. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.
Brugarolas J; Lei K; Hurley RL; Manning BD; Reiling JH; Hafen E; Witters LA; Ellisen LW; Kaelin WG
Genes Dev; 2004 Dec; 18(23):2893-904. PubMed ID: 15545625
[TBL] [Abstract][Full Text] [Related]
17. Growth control under stress: mTOR regulation through the REDD1-TSC pathway.
Ellisen LW
Cell Cycle; 2005 Nov; 4(11):1500-02. PubMed ID: 16258273
[TBL] [Abstract][Full Text] [Related]
18. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth.
Yang X; Yang C; Farberman A; Rideout TC; de Lange CF; France J; Fan MZ
J Anim Sci; 2008 Apr; 86(14 Suppl):E36-50. PubMed ID: 17998426
[TBL] [Abstract][Full Text] [Related]
19. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.
Avruch J; Hara K; Lin Y; Liu M; Long X; Ortiz-Vega S; Yonezawa K
Oncogene; 2006 Oct; 25(48):6361-72. PubMed ID: 17041622
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma.
Schneider A; Younis RH; Gutkind JS
Neoplasia; 2008 Nov; 10(11):1295-302. PubMed ID: 18953439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
